Relationship between bronchial anthracofibrosis and endobronchial tuberculosis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Various pulmonary diseases may be associated with bronchial anthracofibrosis (BAF). Our aim was to identify a relationship between BAF and endobronchial tuberculosis (EBTB). Methods: In total, 156 patients, diagnosed with EBTB using bronchoscopy, between June 1999 and May 2008, were included. Clinical and bronchoscopic findings between patients with BAF (n = 72, BAF group) and without BAF (n = 84, non- BAF) were analyzed retrospectively. Results: The crude odds ratio (OR) of BAF for EBTB was 8.88 (95% confidence interval, 6.37 to 12.37). On multivariate analysis, adjusting for age, history of biomass smoke exposure, and comorbidities, the most significant independent factor for EBTB was a history of biomass smoke exposure (adjusted OR, 17.471; adjusted p < 0.001). EBTB was more frequent in the right lung, particularly the right middle lobar bronchus, in the BAF group. Actively caseating, edematous-hyperemic, and ulcerative were the major types, with 77 (49%), 33 (21%), and 31 cases (20%), respectively. The BAF group had more ulcerative type, while the non-BAF group had more actively caseating type. The duration of EBTB treatment was similar between the groups. No significant difference was observed in the development of complications during treatment and posttreatment bronchostenosis between the groups. Conclusions: These findings suggest that BAF may be a risk factor for EBTB and affect the location and morphological type at the time of EBTB development.
Abstract
Background/Aims: Various pulmonary diseases may be associated with bronchial anthracofibrosis (BAF). Our aim was to identify a relationship between BAF and endobronchial tuberculosis (EBTB). Methods: In total, 156 patients, diagnosed with EBTB using bronchoscopy, between June 1999 and May 2008, were included. Clinical and bronchoscopic findings between patients with BAF (n = 72, BAF group) and without BAF (n = 84, non- BAF) were analyzed retrospectively. Results: The crude odds ratio (OR) of BAF for EBTB was 8.88 (95% confidence interval, 6.37 to 12.37). On multivariate analysis, adjusting for age, history of biomass smoke exposure, and comorbidities, the most significant independent factor for EBTB was a history of biomass smoke exposure (adjusted OR, 17.471; adjusted p < 0.001). EBTB was more frequent in the right lung, particularly the right middle lobar bronchus, in the BAF group. Actively caseating, edematous-hyperemic, and ulcerative were the major types, with 77 (49%), 33 (21%), and 31 cases (20%), respectively. The BAF group had more ulcerative type, while the non-BAF group had more actively caseating type. The duration of EBTB treatment was similar between the groups. No significant difference was observed in the development of complications during treatment and posttreatment bronchostenosis between the groups. Conclusions: These findings suggest that BAF may be a risk factor for EBTB and affect the location and morphological type at the time of EBTB development.
참고문헌 (31)
- Smith LS, "Endobronchial tuberculosis: serial fiberoptic bronchoscopy and natural history", Chest, 91, pp.644~647 (1987)
- Lee JH, "Endobronchial tuberculosis: clinical and bronchoscopic features in 121 cases", Chest, 102, pp.990~994 (1992)
- Kim YH, "Serial fiberoptic bronchoscopic observations of endobronchial tuberculosis before and early after antituberculosis chemotherapy", Chest, 103, pp.673~677 (1993)
- 박은주, "기관지 결핵의 임상상과 내시경소견(1990-2001)", 대한내과학회지, 65(2), pp.284~292 (2003), 대한내과학회
- 안진영, "기관지 결핵의 임상상과 기관지 내시경 소견", Tuberculosis and Respiratory Diseases, 60(5), pp.532~539 (2006), 대한결핵및호흡기학회
- 김휘종, "70세 이상의 고령에서 발생한 기관지 결핵의 임상적 특징", Tuberculosis and Respiratory Diseases, 63(5), pp.412~416 (2007), 대한결핵및호흡기학회
- Kim YJ, "Biomass smoke induced bronchial anthracofibrosis: presenting features and clinical course", Respir Med, 103, pp.757~765 (2009)
- Chung MP, "Bronchial stenosis due to anthracofibrosis", Chest, 113, pp.344~350 (1998)
- Cohen AG., "Atelectasis of the right middle lobe resulting from perforation of tuberculous lymph nodes into bronchi in adults", Ann Intern Med, 35, pp.820~835 (1951)
- Van den Brande PM, "Clinical spectrum of endobronchial tuberculosis in elderly patients", Arch Intern Med, 150, pp.2105~2108 (1990)
- Hwang J, "Bronchial anthracofibrosis and tuberculosis in immigrants to Canada from the Indian subcontinent", Int J Tuberc Lung Dis, 14, pp.231~237 (2010)
- Chung HS, "Bronchoscopic assessment of the evolution of endobronchial tuberculosis", Chest, 117, pp.385~392 (2000)
- Mirsadraee M, "Anthracosis of lung: evaluation of potential underlying causes", J Bronchology, 12, pp.84~87 (2005)
- Mishra VK, "Biomass cooking fuels and prevalence of tuberculosis in India", Int J Infect Dis, 341, pp.119~129 (1999)
- Perez-Padilla R, "Cooking with biomass stoves and tuberculosis: a case control study", Int J Tuberc Lung Dis, 5, pp.441~447 (2001)
- Pokhrel AK, "Tuberculosis and indoor biomass and kerosene use in Nepal: a case-control study", Environ Health Perspect, 118, pp.558~564 (2010)
- Kolappan C, "Association between biomass fuel and pulmonary tuberculosis: a nested casecontrol study", Thorax, 64, pp.705~708 (2009)
- Rajagopalan S., "Tuberculosis and aging: a global health problem", Clin Infect Dis, 33, pp.1034~1039 (2001)
- Zelikoff JT, "The toxicology of the inhaled woodsmoke", J Toxicol Environ Health B Crit Rev, 5, pp.269~282 (2002)
- Kim HY, "Bronchial anthracofibrosis (inf lammatory bronchial stenosis with anthracotic pigmentation): CT findings", AJR Am J Roentgenol, 174, pp.523~527 (2000)
- Smart J., "Endo-bronchial tuberculosis", Br J Tuberc Dis Chest, 45, pp.61~68 (1951)
- Pitchenik AE, "The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS", Am Rev Respir Dis, 131, pp.393~396 (1985)
- Sandoval J, "Pulmonary arterial hypertension and cor pulmonale associated with chronic domestic woodsmoke inhalation", Chest, 103, pp.12~20 (1993)
- Jokinen K, "Bronchial findings in pulmonary tuberculosis", Clin Otolaryngol Allied Sci, 2, pp.139~148 (1977)
- Sung UP, "The effect of steroid on the treatment of endobronchial tuberculosis", Tuberc Respir Dis, 42, pp.130~141 (1995)
- Lee JY, "The clinical features of endobronchial tuberculosis: a retrospective study on 201 patients for 6 years", Tuberc Respir Dis, 43, pp.671~682 (1996)
- Hoheisel G, "Endobronchial tuberculosis: diagnostic features and therapeutic outcome", Respir Med, 88, pp.593~597 (1994)
- Chan HS, "Effect of corticosteroids on deterioration of endobronchial tuberculosis during chemotherapy", Chest, 96, pp.1195~1196 (1989)
- Ip MS, "Endobronchial tuberculosis revisited", Chest, 89, pp.727~730 (1986)
- Gupta A, "Bronchial anthracofibrosis: an emerging pulmonary disease due to biomass fuel exposure", Int J Tuberc Lung Dis, 15, pp.602~612 (2011)
- Bruce N, "Indoor air pollution in developing countries: a major environmental and public health challenge", Bull World Health Organ, 78, pp.1078~1092 (2000)